Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies
Main Author: | Z. Paul Lorenc, MD, FACS |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2017-09-01
|
Series: | Plastic and Reconstructive Surgery, Global Open |
Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000526445.68948.be |
Similar Items
-
Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from a Multi-Center, Open Label, Repeat Dose, Long Term Exposure, Year Long Phase II Safety Study
by: Z. Paul Lorenc, MD, FACS
Published: (2017-09-01) -
Botulinum toxin type A for the management of glabellar rhytids
by: Anne Marie Tremaine, et al.
Published: (2010-04-01) -
Botulinum toxin type-A in the treatment of glabellar lines
by: Leslie Winter, et al.
Published: (2009-12-01) -
Psoriatic lesions following botulinum toxin: A injections to the glabellar region
by: Candemir Ceran, et al.
Published: (2015-01-01) -
Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?
by: Joely Kaufman-Janette, et al.
Published: (2021-07-01)